Skip to main content

High Prevalence of Human Herpesvirus 8 Infection in Diabetes Type 2 Patients and Detection of a New Virus Subtype

  • Chapter
  • First Online:
Advances in Microbiology, Infectious Diseases and Public Health

Abstract

The prevalence of Human Herpesvirus 8 (HHV8) DNA and antiviral antibodies in Diabetes type 2 (DM2) and control subjects was studied, in order to confirm a possible link between DM2 and HHV8 infection. The HHV8-DNA from diabetic patients was typed for detecting possible genomic differences with known HHV8 reference viruses.

DM2 patients and healthy controls were examined for the presence of HHV8 DNA into the peripheral blood lymphocytes. Both anti-lytic and latent phase antibodies were detected in HHV8 positive and negative diabetic patients, as well in a number of controls. The HHV8 ORF K1 and ORF 26 genes from DM2 patients were typed and matched to reference strains.

A significant prevalence of HHV8 DNA in DM2 subjects versus healthy controls was detected (about 58 % against 27 %). Anti-lytic phase, but not anti-latent phase antibodies, were significantly increased in DM2 patients versus controls. In addition, about 30 % of HHV8 strains isolated from DM2 lymphocytes showed consistent differences in the ORF 26 gene sequence, so that a new HHV8 subtype was proposed. These findings give additional support to the hypothesis that HHV8 could be considered an additional risk factor for DM2 onset.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E (2002) Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439–464

    Article  PubMed  PubMed Central  Google Scholar 

  • Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I (2008) Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis 8:111

    Article  PubMed  PubMed Central  Google Scholar 

  • Anderson LA, Li Y, Graubard BI et al (2008) Human herpesvirus 8 seroprevalence among children and adolescents in the United States. Pediatr Infect Dis J 27:661–664

    Article  PubMed  Google Scholar 

  • Angius F, Uda S, Piras E et al (2015) Neutral lipid alterations in human herpesvirus 8-infected HUVEC cells and their possible involvement in neo-angiogenesis. BMC Microbiol 15:74. doi:10.1186/s12866-015-0415-7

    Article  PubMed  PubMed Central  Google Scholar 

  • Caselli E, Rizzo R, Ingianni A, Contini P, Pompei R, Di Luca D (2014) High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus. J Med Virol 86:1745–1751

    Article  CAS  PubMed  Google Scholar 

  • Chakraborty S, Veettil MV, Chandran B (2012) Kaposi’s sarcoma associated herpesvirus entry into target cells. Front Microbiol 3:6. doi:10.3389/fmicb.2012.00006

    CAS  PubMed  PubMed Central  Google Scholar 

  • Chen L, Magliano DJ, Zimmet PZ (2011) The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol 8:228–236

    Article  PubMed  Google Scholar 

  • Chen W, Sin SH, Wen KW, Damania B, Dittmer DP (2012) Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS Pathog 8(11):e1003048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cordiali-Fei P, Trento E, Giovanetti M et al (2015) Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi’s sarcoma and non-Kaposi’s cases. J Exp Clin Cancer Res 34:1. doi:10.1186/s13046-014-0119-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de Souza VA, Pierrotti LC, Sumita LM, Freire WS, Segurado AA, Pannuti CS (2007) Seroreactivity to Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi’s sarcoma patients depends on CD4+ T-cell count. J Med Virol 79:1562–1568

    Article  PubMed  Google Scholar 

  • Endo T, Miura T, Koibuchi T et al (2003) Molecular analysis of human herpesvirus 8 by using single nucleotide polymorphisms in open reading frame 26. J Clin Microbiol 41:2492–2497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Engels EA, Atkinson JO, Graubard BI et al (2007) Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 196:199–207

    Article  PubMed  Google Scholar 

  • Geddes M, Franceschi S, Barchielli A et al (1994) Kaposi’s sarcoma in Italy before and after the AIDS epidemic. Br J Cancer 69:333–336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ingianni A, Carta F, Reina A, Manai M, Desogus A, Pompei R (2007) Prevalence of herpesvirus 8 infection in type 2 diabetes mellitus patients. Am J Infect Dis 3:123–127

    Article  CAS  Google Scholar 

  • Ingianni A, Madeddu MA, Carta F, Reina A, Lai C (2009) Epidemiology of human herpesvirus type 8 infection in cardiopathic patients. OnLine J Biol Sci 9:36–39

    Article  Google Scholar 

  • Ingianni A, Piras E, Laconi S, Angius F, Batetta B, Pompei R (2013) Latent Herpesvirus 8 infection improves both insulin and glucose uptake in primary endothelial cells. New Microbiol 36:257–265

    CAS  PubMed  Google Scholar 

  • Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D (1996) The seroepidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918–924

    Article  CAS  PubMed  Google Scholar 

  • Leao JC, de Faria AB, Fonseca DD, Gueiros LA, Silva IH, Porter SR (2013) Intrahost genetic variability of human herpes virus-8. J Med Virol 85:636–645

    Article  CAS  PubMed  Google Scholar 

  • Mancuso R, Biffi R, Valli M et al (2008) HHV8 a subtype is associated with rapidly evolving classic Kaposi’s sarcoma. J Med Virol 80:2153–2160

    Article  PubMed  PubMed Central  Google Scholar 

  • Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169–181

    Article  PubMed  Google Scholar 

  • Pfeiffer RM, Wheeler WA, Mbisa G et al (2010) Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology. Ann Epidemiol 20:958–963

    Article  PubMed  Google Scholar 

  • Pompei R (2016) The role of human herpesvirus 8 in diabetes mellitus type 2: state of the art and a medical hypothesis. Adv Exp Med Biol 901:37–45

    Article  PubMed  Google Scholar 

  • Pories WJ, Dohm GL (2012) Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 35:2438–2442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rohner E, Wyss N, Trelle S et al (2014) HHV-8 seroprevalence: a global view. Syst Rev 3:11. doi:10.1186/2046-4053-3-11

    Article  PubMed  PubMed Central  Google Scholar 

  • Serraino D, Cerimele D, Piselli P et al (2006) Infection with human herpesvirus type 8 and Kaposi’s sarcoma in Sardinia. Infection 34:39–42

    Article  CAS  PubMed  Google Scholar 

  • Sobngwi E, Choukem SP, Agbalika F et al (2008) Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in Sub-Saharan Africans. JAMA 299:2770–2776

    Article  CAS  PubMed  Google Scholar 

  • Tornesello ML, Biryahwaho B, Downing R et al (2010) Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi’s sarcoma lesions during pre-AIDS and AIDS era. Virology 398:280–289

    Article  CAS  PubMed  Google Scholar 

  • Uldrick TS, Whitby D (2011) Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett 305:150–162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Valdarchi C, Serraino D, Cordiali-Fei P et al (2007) Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy. Infection 35:22–25

    Article  CAS  PubMed  Google Scholar 

  • Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G (1998) Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90:395–397

    Article  CAS  PubMed  Google Scholar 

  • Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321

    Article  PubMed  Google Scholar 

  • WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. WHO Press, Geneva

    Google Scholar 

  • WHO (2015, January) Diabetes 312

    Google Scholar 

  • Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053

    Article  PubMed  Google Scholar 

  • Wu TT, Qian J, Ang J, Sun R (2012) Vaccine prospect of Kaposi sarcoma-associated herpesvirus. Curr Opin Virol 2:482–488

    Article  CAS  PubMed  Google Scholar 

  • Zhu FX, Chong JM, Wu L, Yuan Y (2005) Virion proteins of Kaposi’s sarcoma-associated herpesvirus. J Virol 79:800–811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zong JC, Kajumbula H, Boto W, Hayward GS (2007) Evaluation of global clustering patterns and strain variation over an extended ORF26 gene locus from Kaposi’s sarcoma herpesvirus. J Clin Virol 40:19–25

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The useful help of Mrs Sally Davies for the preparation of the manuscript is kindly acknowledged. This work was sponsored by the Fondazione Banco di Sardegna [No. 0327/2014-15]. The costs to publish in open access were included in funding.

Conflicts of Interest

The authors declare no conflict of interest. The Sponsor had no role in the project designing, in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raffaello Pompei .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Piras, E. et al. (2016). High Prevalence of Human Herpesvirus 8 Infection in Diabetes Type 2 Patients and Detection of a New Virus Subtype. In: Donelli, G. (eds) Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology(), vol 973. Springer, Cham. https://doi.org/10.1007/5584_2016_73

Download citation

Publish with us

Policies and ethics